BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 6201073)

  • 21. Membrane phenotypic studies in B cell lymphoproliferative disorders.
    Scott CS; Limbert HJ; MacKarill ID; Roberts BE
    J Clin Pathol; 1985 Sep; 38(9):995-1001. PubMed ID: 2413082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reactivity of monoclonal antibodies Leu 1 and OKT1 with malignant human lymphoid cells. Correlation with conventional cell markers.
    Knowles DM; Halper JP; Azzo W; Wang CY
    Cancer; 1983 Oct; 52(8):1369-77. PubMed ID: 6193856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surface phenotype and clinical stages in B-cell chronic lymphocytic leukaemia.
    Orfao A; Gonzalez M; San Miguel JF; Moro MJ; Fernandez-Calvo J; Carnero M; Galindo P; Lopez Borrasca A
    Haematologica; 1987; 72(1):39-43. PubMed ID: 3108093
    [No Abstract]   [Full Text] [Related]  

  • 24. Intermediate lymphocytic lymphoma: an immunohistologic study with comparison to other lymphocytic lymphomas.
    Weisenburger DD; Linder J; Daley DT; Armitage JO
    Hum Pathol; 1987 Aug; 18(8):781-90. PubMed ID: 3301625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the Leu-8 antigen by B-cell lymphomas.
    Michie SA; Garcia CF; Strickler JG; Dailey MO; Rouse RV; Warnke RA
    Am J Clin Pathol; 1987 Oct; 88(4):486-90. PubMed ID: 3310610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibody phenotyping of B-cell non-Hodgkin's lymphomas. The Southeastern Cancer Study Group experience.
    Borowitz MJ; Bousvaros A; Brynes RK; Cousar JB; Crissman JD; Whitcomb CC; Kerns BJ; Byrne GE
    Am J Pathol; 1985 Dec; 121(3):514-21. PubMed ID: 2933960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic changes in large cell transformation of small cell lymphoid malignancies.
    Chan WC; Dekmezian R
    Cancer; 1986 May; 57(10):1971-8. PubMed ID: 3082507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization and classification of rat leukemias and lymphomas by membrane markers.
    Moriuchi T; Kasai M; Yamaguchi H; Kobayashi H
    Cancer Res; 1981 May; 41(5):1938-42. PubMed ID: 6111394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypic and functional analyses of tumour-infiltrating Leu 7 + natural killer-like cells in non-Hodgkin lymphomas.
    Banerjee D
    Cancer Detect Prev Suppl; 1987; 1():103-9. PubMed ID: 3500777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Lymphomas and immunity].
    Kouvalainen K
    Duodecim; 1970; 86(16):886-94. PubMed ID: 4917099
    [No Abstract]   [Full Text] [Related]  

  • 31. B-cell neoplasms of the lymphocytic, lymphoplasmacytoid, and plasma cell types: immunohistologic analysis and clinical correlation.
    Harris NL; Bhan AK
    Hum Pathol; 1985 Aug; 16(8):829-37. PubMed ID: 3926626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of molecular genetics on the study of lymphoid neoplasia.
    Harris NL
    Lab Invest; 1985 Nov; 53(5):509-12. PubMed ID: 3932777
    [No Abstract]   [Full Text] [Related]  

  • 33. Leukemia derived from intermediately differentiated lymphocytic lymphoma.
    Elias JM; Fromowitz F; Golightly M; Lane B; Sabet S
    Pathol Res Pract; 1988 Feb; 183(1):54-64. PubMed ID: 3283712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity of marker expression in B-cell leukemias and its diagnostic significance.
    Menon M; Drexler HG; Minowada J
    Leuk Res; 1986; 10(1):25-8. PubMed ID: 3080642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of CD 25 (Tac antigen) in lymphoid leukemias and non-Hodgkin lymphomas.
    Faure GC; Bene MC; Bolle-Chanal MH
    Eur J Haematol; 1987 Jan; 38(1):26-30. PubMed ID: 3034662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cell surface markers of childhood leukemias and lymphomas].
    Shibuya A; Shinozawa T; Yoshikawa T; Katayama I
    Rinsho Ketsueki; 1985 Jan; 26(1):7-14. PubMed ID: 3158761
    [No Abstract]   [Full Text] [Related]  

  • 37. Alkaline phosphatase-positive malignant lymphoma. A subtype of B-cell lymphomas.
    Nanba K; Jaffe ES; Braylan RC; Soban EJ; Berard CW
    Am J Clin Pathol; 1977 Nov; 68(5):535-42. PubMed ID: 335871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inference of cellular origin and differentiation stage of B-cell malignancies using multiple immunological markers.
    Minato K; Shimoyama M; Seki S
    Nihon Ketsueki Gakkai Zasshi; 1984 Dec; 47(8):1567-78. PubMed ID: 6085204
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of chronic lymphocytic leukemia (CLL) cells with low density of surface membrane bound immunoglobulins (smIg).
    Kimby E; Axelsson B; Björkholm M; Gordon J; Holm G; Mellstedt H
    Med Oncol Tumor Pharmacother; 1985; 2(4):261-7. PubMed ID: 2935687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Well-differentiated B cell lymphomas/leukaemias express IL-2 receptors identified by immunofluorescence and flow cytometry.
    de Paoli P; Santini GF
    Clin Exp Immunol; 1987 Apr; 68(1):223-4. PubMed ID: 3115641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.